peerreview
marin
pharmacolog
literatur
cover
review
follow
similar
format
previou
review
seri
preclin
pharmacolog
structur
character
marin
compound
isol
marin
anim
alga
fungi
bacteria
discuss
comprehens
manner
antibacteri
anticoagul
antifung
antimalari
antiprotozo
antituberculosi
antivir
activ
report
marin
natur
product
addit
marin
compound
report
affect
cardiovascular
immun
nervou
system
well
possess
antiinflammatori
effect
final
marin
metabolit
shown
bind
varieti
receptor
miscellan
molecular
target
thu
upon
complet
mechan
action
studi
contribut
sever
pharmacolog
class
marin
pharmacolog
research
remain
global
enterpris
research
countri
unit
state
contribut
preclin
pharmacolog
marin
compound
part
preclin
marin
pharmaceut
pipelin
sustain
preclin
research
marin
natur
product
demonstr
novel
pharmacolog
activ
probabl
result
expans
current
marin
pharmaceut
clinic
pipelin
current
consist
marin
natur
product
analog
deriv
target
limit
number
diseas
categori
current
articl
present
preclin
pharmacolog
marin
natur
product
maintain
format
use
previou
review
mayer
lehmann
mayer
hamann
mayer
et
al
mayer
et
al
preclin
pharmacolog
antitumor
cytotox
marin
compound
report
separ
review
mayer
mayer
lehmann
mayer
gustafson
restrict
current
well
previou
review
peerreview
articl
report
bioactiv
pharmacolog
structur
character
marin
compound
done
previous
continu
use
modif
schmitz
chemic
classif
schmitz
et
al
assign
marin
natur
product
structur
six
major
chemic
class
name
polyketid
terpen
peptid
alkaloid
shikim
sugar
novel
antibacteri
anticoagul
antifung
antimalari
antiprotozo
antituberculosi
antivir
preclin
pharmacolog
marin
metabolit
present
tabl
correspond
structur
shown
fig
marin
compound
affect
immun
nervou
system
well
antiinflammatori
effect
group
tabl
correspond
structur
present
fig
final
marin
compound
demonstr
affect
varieti
cellular
molecular
target
exhibit
tabl
structur
depict
fig
sever
articl
publish
report
preclin
pharmacolog
extract
structur
uncharacter
marin
compound
although
includ
present
review
probabl
may
warrant
investig
antimicrobi
effect
turkish
red
alga
jania
ruben
karabayyavasoglu
et
al
antimicrobi
activ
portugues
marin
cyanobacteria
synechocysti
sp
synechococcu
sp
extract
toward
gramposit
bacteria
martin
et
al
antibacteri
activ
human
fish
bacteria
subarct
coloni
ascidian
synoicum
pulmonaria
northern
norway
tadess
et
al
strong
antibioticproduc
potenti
actinomycet
sediment
trondheim
fjord
norway
bredholt
et
al
antibacteri
activ
deepsea
bacteria
sediment
west
pacif
ocean
potent
antimicrobi
activ
green
alga
enteromorpha
intestinali
collect
gujarat
india
nair
et
al
nonhemolyt
antimicrobi
lipopeptid
deriv
marin
bacterium
bacillu
circulan
da
et
al
tantigen
bind
lectin
bioactiv
broad
spectrum
gramposit
gramneg
bacteria
sea
cucumb
holothuria
scabra
gowda
et
al
anticoagul
activ
kda
polysaccharid
isol
ferment
red
seawe
lomentaria
catenata
greater
clinic
anticoagul
heparin
pushpamali
et
al
antimycobacteri
activ
longchain
fatti
acid
isol
red
alga
polysiphonia
virgata
saravanakumar
et
al
antileishmani
antitrichomon
activ
organ
extract
sever
mexican
red
brown
alga
moopuc
et
al
activ
novel
sulfat
galactan
isol
chines
red
alga
grateloupia
longifolia
grateloupia
filicina
signific
antiherp
simplex
viru
activ
kda
polysaccharid
isol
red
alga
gracilaria
corticata
immunomodulatori
effect
enzymat
extract
south
korean
marin
brown
alga
ecklonia
cava
murin
splenocyt
ahn
et
al
immunostimul
properti
sulfat
polysaccharid
isol
brazilian
red
alga
champia
feldmannii
antioxid
antimicrobi
activ
indian
red
brown
seawe
methanol
extract
high
phenol
content
devi
et
al
decreas
express
key
regulatori
gene
involv
cholesterol
fatti
acid
biosynthet
pathway
lipid
extract
cyanobacterium
nostoc
commun
var
sphaeroid
rasmussen
et
al
marin
compound
antibacteri
anticoagul
antifung
antimalari
antiprotozo
antituberculosi
antivir
activ
tabl
present
preclin
pharmacolog
report
antibacteri
anticoagul
antifung
antimalari
antiprotozo
antituberculosi
antivir
pharmacolog
marin
natur
product
shown
fig
contribut
global
search
new
antimicrobi
combat
antibioticresist
strain
pathogen
bacteria
marin
ecolog
nich
describ
recent
particularli
promis
fischbach
walsh
studi
report
novel
antibacteri
marin
natur
product
isol
marin
bacteria
fungi
spong
worm
fish
larger
effort
one
report
previou
year
mayer
et
al
previou
review
seri
six
paper
provid
detail
mechan
action
studi
marin
antimicrobi
compound
kanoh
et
al
report
discoveri
novel
bioactiv
spirodioxynaphthalen
ascochytatin
isol
cultur
marinederiv
fungu
ascochyta
sp
inhibit
b
subtili
growth
mid
target
function
bacteri
growth
regulatori
system
tc
yycgyycf
kitani
et
al
discov
kda
acid
glycoprotein
lamino
acid
oxidas
term
ssap
isol
rockfish
sebast
schlegelli
kitani
et
al
act
select
gramneg
bacteria
minimum
inhibitori
concentr
mic
h
shown
mediat
antibacteri
action
ssap
electron
microscopi
analysi
reveal
ssap
induc
cell
surfac
damag
morpholog
chang
sever
bacteri
speci
report
peptid
isol
marin
polychaet
arenicola
marina
exhibit
signific
antibacteri
activ
p
aeruginosa
staphylococcu
aureu
mic
interestingli
induc
releas
calcein
pepg
liposom
thu
suggest
bacteri
cell
membran
main
molecular
target
peptid
jang
et
al
extend
pharmacolog
alkaloid
isoaaptamin
isol
marin
spong
aaapto
aapto
isoaaptamin
inhibit
sortas
ic
enzym
involv
aureu
cell
wall
protein
anchor
virul
thu
potenti
provid
novel
lead
compound
develop
potent
antibacteri
lee
et
al
isol
seven
sesterterpen
tropic
spong
dysidea
sp
demonstr
antibacteri
activ
b
subtili
mic
inhibit
isocitr
lyas
activ
key
enzym
glyoxyl
cycl
present
prokaryot
lower
eukaryot
plant
vertebr
kanoh
et
al
describ
new
sulfoalkylresorcinol
isol
kossuga
et
al
continu
next
page
marinederiv
fungu
zygosporium
sp
show
antimicrobi
activ
methicillinresist
aureu
mechan
action
appear
involv
inhibit
ic
ml
vitro
polymer
ftsz
protein
structur
homolog
eukaryot
tubulin
particip
bacteri
cell
divis
shown
tabl
sever
new
marin
antibacteri
also
report
fig
mic
less
antibioticresist
bacteri
strain
although
mechan
action
studi
report
alkaloid
ambiguin
isonitril
h
isol
marin
cyanobacterium
fischerella
sp
raveh
carm
polyketid
ariakemicin
b
isol
marin
glide
bacterium
rapidithrix
sp
oku
et
al
ayamycin
isol
bacterium
nocardia
sp
alaa
elgendi
et
al
alkaloid
batzelladin
l
isol
caribbean
spong
monanchora
unguifera
hua
et
al
diphenyl
ether
isol
indonesian
spong
lamellodysidea
herbacea
hanif
et
al
essramycin
obtain
cultur
broth
marin
streptomyc
sp
isol
elgendi
et
al
meroditerpen
isojasp
acid
isol
papua
new
guinean
spong
cacospongia
sp
rubio
et
al
bisindol
pyrrol
lynamicin
ad
isol
novel
marin
actinomycet
marinispora
sp
mcarthur
et
al
lipoxazolidinon
b
isol
marin
actinomycet
marinispora
sp
macherla
et
al
marinopyrrol
isol
oblig
marin
streptomyc
strain
hugh
et
al
furanosesquiterpen
isol
marin
spong
fasciospongia
sp
gaspar
et
al
macrolid
phomolid
b
isol
fungu
phomopsi
sp
sargaquino
acid
deriv
isol
brown
alga
sargassum
sagamianum
hori
et
al
tauramamid
lipopeptid
isol
bacterium
brevibacillu
laterosporu
desjardin
et
al
furthermor
period
sever
novel
marin
metabolit
moder
antimicrobi
activ
mic
ic
rang
respect
also
report
weaker
antibacteri
activ
preclud
inclus
either
tabl
fig
acetylmajapolen
mic
vairappan
et
al
callophyco
acid
b
g
h
mic
lane
et
al
corallidicty
b
c
mic
less
ml
curcuphenol
analog
ic
gul
et
al
cyclomarazin
b
mic
ml
schultz
et
al
dehydroxychlorofusarielin
b
mic
nguyen
et
al
nodosol
mic
ml
kontiza
et
al
paeciloxanthon
mic
palmitol
acid
ic
desboi
et
al
puupehenonemetabolit
mic
tripalea
clavaria
csecosteroid
mic
rodriguez
brasco
et
al
shishididemniol
b
mic
kobayashi
et
al
zafrin
mic
uzair
et
al
noteworthi
report
novel
marin
antimicrobi
peptid
dicentracin
new
compon
moronecidin
famili
isol
head
kidney
leukocyt
sea
bass
dicentrarchu
labrax
salerno
et
al
hepcidin
three
novel
antimicrobi
peptid
isol
tilapia
oreochromi
mossambicu
mic
listeria
monocytogen
aureu
enterococcu
faecium
huang
et
al
scygonadin
novel
anion
antimicrobi
peptid
semin
plasma
mud
crab
scylla
serrata
tunichrom
small
dehydrodopaminecontain
peptid
found
hemocyt
cell
ascidian
ascidia
nigra
capabl
crosslink
protein
vitro
cai
et
al
four
articl
publish
report
anticoagul
marin
natur
product
isol
alga
clam
number
similar
report
previou
review
mayer
et
al
review
marin
pharmacolog
seri
jung
et
al
character
novel
kda
anticoagul
polypeptid
term
tgap
partial
sequenc
muscl
protein
south
korean
bivalv
tegillarca
granosa
anticoagul
polypeptid
demonstr
low
vitro
cytotox
venou
endotheli
cell
specif
inhibit
blood
coagul
factor
va
well
molecular
interact
factor
iia
factor
va
ascochytatin
thrombin
well
potenti
antithrombin
iiimedi
inhibit
coagul
factor
xa
ten
studi
report
antifung
activ
sever
novel
marin
natur
product
isol
marin
alga
bacteria
spong
sea
cucumb
decreas
last
review
mayer
et
al
previou
review
seri
shown
tabl
one
report
extend
molecular
pharmacolog
novel
antifung
marin
metabolit
symphyocladia
latiuscula
bromophenol
furthermor
sever
marin
natur
product
show
signific
antifung
activ
ie
mic
either
less
tabl
fig
although
mechan
action
studi
report
publish
articl
callipeltin
j
k
mic
auria
et
al
triterpen
glycosid
holothurin
b
mic
ml
kumar
et
al
macrolid
neopeltolid
mic
cyclopeptid
pedein
mic
kunz
et
al
pseudoceratin
b
mic
jang
et
al
hope
futur
studi
molecular
pharmacolog
marin
compound
elucid
mechan
action
final
sever
novel
structur
character
marin
molecul
isol
spong
demonstr
mic
ic
greater
ml
therefor
report
weaker
antifung
activ
exclud
tabl
fig
eurysterol
b
mic
boonlarppradab
faulkner
nagelamid
n
mic
kubota
et
al
nortetillapyron
mic
wattanadilok
et
al
tydemania
expeditioni
triterpenoid
ic
jiang
et
al
marin
compound
may
yet
provid
addit
pharmacolog
lead
ongo
global
search
clinic
use
antifung
agent
shown
tabl
increas
previou
review
mayer
et
al
previou
review
seri
shown
tabl
nine
marin
molecul
shown
possess
signific
antimalari
activ
although
mechan
action
studi
report
two
compound
tasdemir
et
al
report
e
oroidin
e
oroidin
tfa
salt
isol
turkish
marin
spong
agela
oroid
potent
inhibit
cultur
multidrug
resist
strain
plasmodium
falciparum
ic
respect
concomit
inhibit
fabi
enoylacp
reductas
key
enzym
type
ii
fatti
acid
synthas
cascad
ic
respect
studi
reveal
oroidin
free
base
appear
bind
enzymesubstr
complex
enzymecofactor
complex
uncompetit
mechan
provid
pharmacolog
character
first
antimalari
marin
natur
product
target
p
falciparum
fabi
addit
antimalari
activ
report
seven
marin
compound
two
report
contribut
panama
intern
cooper
biodivers
group
project
mcphail
et
al
isol
novel
linear
lipopeptid
dragomabin
cyanobacterium
lyngbya
majuscula
moder
antimalari
activ
ic
signific
differenti
toxic
malari
parasit
mammalian
cell
linington
et
al
discov
new
cyclic
hexapeptid
venturamid
b
isol
panamanian
marin
cyanobacterium
oscillatoria
sp
demonstr
signific
vitro
antiplasmodi
activ
chloroquinoneresist
strain
parasit
ic
mild
cytotox
mammalian
cell
first
exampl
identif
cyanobacteri
peptid
select
antimalari
activ
kasettrathat
et
al
prove
new
tetron
acid
nodulisporacid
marinederiv
fungu
nodulisporium
sp
isol
thai
soft
coral
moder
antiplasmodi
ic
chloroquineresist
p
falciparum
strain
na
et
al
identifi
new
marin
streptomyc
sp
polyeth
hawaii
show
vitro
antimalari
activ
ic
p
falciparum
chloroquinesuscept
resist
clone
minim
cytotox
toward
mammalian
cell
clark
et
al
found
novel
acylprolin
deriv
tumono
acid
papua
new
guinean
marin
cyanobacterium
blennothrix
cantharidosmum
show
moder
antimalari
activ
p
falciparum
ic
pontiu
et
al
isol
heterocyclicsubstitut
xanthon
chaetoxanthon
b
cultur
marinederiv
fungu
chaetomium
sp
show
select
activ
toward
p
falciparum
strain
ic
four
marin
compound
report
possess
antiprotozo
activ
kossuga
et
al
reisol
previous
report
plakortid
p
marin
spong
plakorti
angulospiculatu
compound
display
select
effect
leishmania
chagasi
ic
trypanosoma
cruzi
ic
ml
low
concomit
hemolyt
cytotox
activ
toward
human
macrophag
reportedli
mechan
action
toward
intracellular
l
chagasi
appear
involv
nitric
oxid
simmon
et
al
found
two
novel
lipopeptid
viridamid
b
nearli
equipot
inhibit
leishmania
mexicana
ic
cruzi
ic
besid
antimalari
activ
pontiu
et
al
discov
chaetoxanthon
b
select
effect
toward
cruzi
ic
ml
minim
cytotox
toward
rat
skelet
myoblast
ic
ten
new
marin
compound
report
global
search
novel
antituberculosi
agent
consider
increas
previou
review
mayer
et
al
previou
review
seri
ospina
et
al
isol
bioactiv
oxapolycycl
diterpen
bipinnapterolid
b
colombian
gorgonian
coral
pseudopterogorgia
bipinnata
weakli
inhibit
growth
tuberculosi
h
rv
inhibit
zhang
et
al
identifi
two
new
dimer
marinederiv
fungu
aspergillu
carbonariu
show
weak
antimycobacteri
activ
tuberculosi
h
rv
mic
respect
interestingli
presenc
conjug
ccco
bond
pyran
ring
appear
crucial
antifung
activ
result
continu
investig
caribbean
sea
whip
pseudopterogorgia
elisabetha
wei
et
al
report
novel
tricarbocycl
norditerpen
caribenol
b
weakli
inhibit
tuberculosi
h
rv
mic
respect
furthermor
wei
et
al
discov
two
novel
ring
b
abeosterol
parguesterol
b
caribbean
spong
svenzea
zeai
inhibit
tuberculosi
h
rv
mic
respect
hope
futur
inform
select
index
two
compound
provid
addit
inform
support
notion
might
constitut
import
lead
structur
develop
novel
tuberculosi
drug
due
strong
activ
specif
low
toxic
berru
et
al
note
sever
bioactiv
polyketid
acid
dinorspiculo
acid
norspiculo
acid
caribbean
spong
plakorti
zyggompha
also
inhibit
tuberculosi
h
rv
mic
although
studi
demonstr
marin
terpen
polyketid
constitut
potenti
novel
antituberculosi
lead
unfortun
provid
detail
mechan
action
pharmacolog
time
public
shown
tabl
three
report
publish
antivir
pharmacolog
novel
marin
natur
product
sever
acut
respiratori
syndrom
sar
corona
viru
herp
simplex
dengu
viru
de
lira
et
al
discov
new
acid
ethyl
ester
brazilian
marin
spong
axinella
cf
corrugata
inhibit
sar
proteas
ic
potenti
signific
find
proteas
high
profil
target
sar
drug
develop
appear
involv
releas
replic
viral
protein
well
rna
polymeras
talarico
et
al
report
lgalactan
hybrid
isol
brazilian
marin
alga
cryptonemia
crenulata
show
potent
antivir
activ
three
clinic
strain
dengu
viru
serotyp
ic
togeth
low
cytotox
mechanist
work
determin
appear
promis
entri
inhibitor
mandal
et
al
describ
sulfat
xylomannan
isol
indian
red
seawe
scinaia
hatei
inhibit
ic
low
cytotox
probabl
interf
multipl
cycl
interestingli
good
antivir
activ
wide
spectrum
hsv
strain
test
suggest
compound
might
good
candid
preclin
research
five
report
contribut
preclin
pharmacolog
marin
compound
activ
human
immunodefici
viru
caus
agent
acquir
immunodefici
diseas
syndrom
aid
increas
previou
review
mayer
et
al
previou
review
seri
artan
et
al
report
phlorglucinol
deriv
isol
brown
alga
e
cava
inhibit
hivinduc
syncytia
format
ic
viral
antigen
product
ic
activ
hiv
revers
transcriptas
ic
cytotox
concentr
inhibit
hiv
replic
almost
complet
cirnesanto
et
al
extend
molecular
pharmacolog
diterpen
dolabelladienetriol
isol
marin
brown
alga
dictyota
pfaffii
dolabellan
diterpen
block
synthesi
integr
proviru
noncompetit
inhibit
revers
transcriptas
enzym
ki
investig
propos
dolabelladienetriol
potenti
new
agent
therapi
plaza
et
al
describ
three
new
depsipeptid
mirabamid
c
isol
spong
siliquariaspongia
mirabili
potent
inhibit
neutral
ic
envelopemedi
cell
fusion
ic
suggest
compound
act
earli
stage
cell
infect
presum
interact
envelop
protein
lu
et
al
ad
novel
mechanist
profil
previous
report
sulfat
polymannuroguluron
spmg
polysaccharid
averag
molecular
weight
kda
isol
brown
alga
laminaria
japonica
report
phase
ii
clinic
trial
china
antiaid
drug
candid
spmg
appear
elimin
viral
gene
product
known
transactiv
transcript
protein
tat
induc
signal
transduct
well
angiogenesi
aidsassoci
kaposi
sarcoma
cell
furthermor
hui
et
al
demonstr
spmg
appear
show
neuroprotect
effect
decreas
apoptosi
caus
tatstimul
calcium
overload
neuron
cell
thu
suggest
spmg
might
warrant
clinic
studi
hivassoci
dementia
tabl
summar
preclin
pharmacolog
research
complet
marin
compound
shown
fig
antiinflammatori
pharmacolog
marin
compound
report
show
consider
increas
previou
review
mayer
et
al
previou
review
seri
sever
marin
natur
product
shown
preclin
pharmacolog
studi
target
arachidon
metabol
neutrophil
macrophag
pearc
et
al
report
two
new
tricycl
alkaloid
ascidiathiazon
b
isol
new
zealand
ascidian
aplidium
speci
affect
superoxid
product
human
neutrophil
vitro
ic
well
murin
periton
neutrophi
ex
vivo
concomit
low
nonexist
liver
renal
toxic
thu
suggest
two
compound
might
becom
potenti
antiinflammatori
pharmaceut
lead
chao
et
al
identifi
new
cembranolid
crassumolid
c
soft
coral
lobophytum
crassum
inhibit
express
ino
appar
ic
less
similarli
univers
cheng
et
al
found
new
cembranolid
soft
coral
lobophytum
duru
durumolid
ac
inhibit
ino
protein
lpsactiv
raw
cell
vitro
appar
ic
less
suggest
moieti
compound
necessari
observ
activ
shen
et
al
show
new
briaranetyp
diterpenoid
frajunolid
b
c
isol
taiwanes
gorgonian
junceella
fragili
significantli
inhibit
superoxid
anion
elastas
gener
human
neutrophil
vitro
appar
ic
greater
dang
et
al
demonstr
previous
describ
fatti
acid
south
korean
marin
red
alga
gracilaria
verrucosa
inhibit
releas
lpsactiv
murin
macrophag
inflammatori
nitric
oxid
tumor
necrosi
factor
appar
ic
less
thu
reveal
conjug
enon
moieti
play
critic
role
antiinflammatori
activ
observ
vitro
bittencourt
et
al
contribut
novel
preclin
pharmacolog
previous
report
amino
acid
polypeptid
isol
red
alga
hypnea
cervicorni
mucinbind
agglutinin
extens
character
sever
vivo
model
nocicept
inflamm
probabl
exert
antiinflammatori
activ
appar
ic
mgkg
via
interact
polypeptid
lectin
carbohydratebind
site
although
exact
mechan
action
remain
undetermin
el
say
et
al
demonstr
manzamin
potent
inhibit
txb
gener
ic
less
respect
brain
microglia
find
provid
support
notion
manzamin
alkaloid
appear
viabl
antiinflammatori
lead
preclin
pharmaceut
develop
agent
modul
activ
brain
microglia
eicosanoid
gener
treschow
et
al
investig
four
novel
polyunsatur
fatti
acid
new
zealand
greenlip
mussel
perna
canaliculu
vitro
bioassay
use
stimul
human
neutrophil
demonstr
put
antiinflammatori
potenti
compound
might
relat
inhibit
leukotrien
prostaglandin
metabolit
product
sansom
et
al
report
bisprenyl
quinon
new
zealand
brown
alga
perithalia
capillari
inhibit
superoxid
anion
product
human
neutrophil
ic
vitro
low
toxic
explan
author
decid
investig
quinon
antiinflammatori
lead
remain
unclear
although
strongli
cytotox
toward
human
leukemia
cell
ic
sugiura
et
al
character
novel
antiallerg
phlorotannin
phlorofucofuroeckol
b
pffb
edibl
brown
alga
eisenia
arborea
pffb
inhibit
releas
rat
basophil
leukemia
cell
ic
vitro
thu
show
higher
potenc
tranilast
ic
pharmaceut
agent
use
treatment
allerg
disord
asthma
allerg
rhiniti
atop
dermat
japan
south
korea
kossuga
et
al
demonstr
polyketid
plakortid
p
isol
brazilian
spong
p
angulospiculatu
potent
inhibit
thromboxan
b
releas
ic
activ
rat
brain
microglia
thu
extend
preclin
pharmacolog
compound
besid
antiparasit
discuss
earlier
review
also
appear
potenti
novel
antineuroinflammatori
agent
pearc
et
al
examin
halogen
furanon
rubrolid
isol
new
zealand
ascidian
synoicum
n
sp
inhibit
superoxid
anion
product
human
neutrophil
ic
vitro
low
toxic
although
rubrolid
report
cytotox
antibacteri
author
propos
antiinflammatori
activ
tunic
metabolit
though
moder
unpreced
khan
et
al
identifi
polyunsatur
fatti
acid
stearidon
acid
south
korean
brown
seawe
undaria
pinnatifida
shown
activ
pmainduc
mous
ear
inflamm
symptom
edema
erythema
blood
flow
ic
ear
respect
vivo
data
compar
well
indomethacin
use
posit
control
ic
ear
respect
thu
support
claim
seawe
use
remedi
inflammationrel
symptom
kobayashi
et
al
discov
novel
dimer
oroidin
deriv
carteramin
marin
spong
stylissa
carteri
show
inhibit
neutrophil
chemotaxi
ic
author
suggest
carteramin
structur
resembl
known
compound
inhibit
neutrophil
chemotaxi
find
provid
novel
platform
develop
new
class
antiinflammatori
agent
taori
et
al
identifi
three
new
analogu
dolastatin
lyngbyastatin
isol
marin
cyanobacteria
lyngbya
spp
south
florida
although
three
compound
select
potent
inhibit
porcin
pancreat
elastas
ic
nm
suggest
potenti
therapeut
use
pathophysiolog
condit
elastas
overact
involv
mechan
action
studi
report
time
oh
et
al
purifi
novel
polyketid
salinipyron
marin
actinomycet
salinispora
pacifica
moder
inhibit
ic
mous
splenocyt
model
allerg
inflamm
low
cell
cytotox
pharmacolog
marin
compound
report
activ
immun
system
show
consider
increas
previou
review
mayer
et
al
previou
review
seri
kawauchi
et
al
investig
red
pigment
cycloprodigiosin
hydrochlorid
isol
marin
bacterium
pseudoalteromona
denitrifican
interestingli
compound
suppress
activ
protein
appar
ic
downstream
gene
express
interleukin
chemokin
involv
innat
immun
system
courtoi
et
al
assess
effect
known
compound
floridosid
isol
french
red
alga
mastocarpu
stellatu
complement
system
floridosid
observ
potent
activ
classic
complement
pathway
appar
ic
recruit
immunoglobulin
igm
suggest
compound
might
import
step
develop
potent
new
anticomplementari
agent
use
therapi
aim
address
complement
deplet
greve
et
al
report
novel
isoiantheran
purifi
australian
marin
spong
ianthella
quadrangulata
demonstr
agonist
activ
receptor
ic
respect
find
repres
interest
contribut
ionotrop
purin
receptor
pharmacolog
receptor
shown
affect
matur
differenti
dendrit
cell
huh
et
al
extend
pharmacolog
prodigiosin
isol
marin
bacterium
hahella
chejuenc
collect
south
korea
prodigiosin
inhibit
ino
mrna
express
product
appar
ic
mechan
involv
inhibit
mapk
jnk
phosphoryl
et
al
character
pharmacolog
water
solubl
polysaccharid
isol
mollusc
arca
subcrenata
lischk
popular
chines
seafood
name
aslp
aslp
stimul
mous
spleen
lymphocyt
prolifer
concentrationdepend
manner
appar
ic
less
branch
aslp
requir
immunomodulatori
bioactiv
aminin
et
al
describ
immunostimul
activ
frondosid
triterpen
glycosid
isol
sea
cucumb
cucumaria
frondosa
glycosid
shown
stimul
lysosom
activ
phagocytosi
mous
macrophag
well
reactiv
oxygen
speci
format
oda
et
al
provid
novel
inform
molecular
mechan
affect
smenospongidin
smenospongiarin
smenospongin
sesquiterpen
quinon
previous
isol
palauan
marin
spong
hippospongia
sp
observ
compound
promot
releas
member
cxc
chemokin
superfamili
involv
tumor
progress
metastasi
suggest
function
group
might
play
yet
undetermin
role
observ
result
yamada
et
al
isol
novel
macrosphelid
peribysin
j
periconia
byssoid
fungal
strain
discov
sea
hare
aplysia
kurodai
significantli
fungal
metabolit
inhibit
adhes
human
promyelocyt
leukemia
cell
human
umbil
vein
endotheli
cell
ic
respect
potent
herbimycin
ic
latter
compound
benzochinoid
ansamycin
antibiot
isol
streptomyc
sp
use
posit
control
studi
lu
et
al
contribut
novel
cembranolid
querciformolid
c
soft
coral
sinularia
querciformi
significantli
inhibit
activ
ino
enzym
appar
ic
less
lpsactiv
murin
macrophag
vitro
ponomarenko
et
al
discov
new
diterpenoid
isol
northern
cook
island
marin
spong
spongia
heterofibria
sp
moder
activ
murin
splenocyt
lysosom
appar
ic
greater
oh
et
al
character
novel
cyclic
peptid
thalassospiramid
b
isol
marin
bacterium
thalassospira
sp
show
immunosuppress
activ
inhibit
assay
ic
interest
find
express
eosinophil
mast
cell
asthmat
patient
pharmacolog
studi
marin
compound
affect
nervou
system
involv
three
area
neuropharmacolog
stimul
neurogenesi
target
receptor
miscellan
activ
nervou
system
marin
natur
product
report
neuritogen
might
use
treat
damag
neuron
cell
potenti
neurodegen
diseas
shown
tabl
compound
isol
sea
star
brown
alga
observ
enhanc
neuritogen
properti
nerv
growth
factor
ngf
compound
critic
role
differenti
surviv
neuron
regener
kicha
et
al
contribut
two
new
steroid
glycosid
linckosid
isol
vietnames
blue
sea
star
linckia
laevigata
three
glycosid
appar
ic
show
synergist
effect
ngfinduc
ngml
neurit
outgrowth
murin
neuroblastoma
cell
han
et
al
contribut
novel
steroid
glycosid
linckosid
mq
japanes
sea
star
l
laevigata
linckosid
p
induc
neurit
outgrowth
rat
pheochromocytoma
cell
presenc
nerv
growth
factor
ngf
linckosid
mo
appear
less
activ
suggest
import
xylos
side
chain
ina
et
al
character
pheophytin
purifi
japanes
brown
alga
sargassum
fulvellum
novel
neurodifferenti
compound
pheophytin
observ
synerg
ngf
ngml
promot
neurit
outgrowth
rat
pheochromocytoma
cell
mechan
appear
involv
activ
mitogenactiv
protein
kinas
signal
shown
tabl
three
marin
compound
report
target
receptor
nervou
system
peng
et
al
report
preclin
pharmacolog
origin
isol
marin
cone
snail
conu
leopardu
conotoxin
induc
seizur
paralysi
goldfish
select
yet
revers
inhibit
acetylcholineevok
current
xenopu
oocyt
express
rat
nicotin
receptor
appar
ic
less
aiello
et
al
character
two
novel
bromopyrrol
alkaloid
damipipecolin
damituricin
isol
mediterranean
spong
axinella
damicorni
observ
modul
serotonin
receptor
activ
vitro
although
damipipecolin
inhibit
ca
entri
neuron
appar
ic
serotonin
receptor
subtyp
involv
mechan
action
remain
undetermin
final
shown
tabl
addit
marin
compound
report
miscellan
effect
compon
nervou
system
contribut
ongo
search
acetylcholinesteras
inhibitor
use
treatment
alzheim
diseas
langja
et
al
report
new
stigmastanetyp
steroid
alkaloid
b
isol
thai
marin
spong
corticium
sp
significantli
inhibit
acetylcholinesteras
ic
compound
report
first
marinederiv
acetylcholinesteraseinhibit
steroid
alkaloid
mechan
action
involv
unusu
mixedcompetit
mode
inhibit
choi
et
al
extend
molecular
pharmacolog
two
known
meroditerpen
sargaquino
acid
sargachromenol
isol
brown
alga
sagamianum
sargaquino
acid
potent
inhibit
butyrylcholinesteras
ic
nm
novel
target
treatment
alzheim
diseas
potenc
compar
greater
anticholinesteras
current
clinic
use
hui
et
al
character
neuroprotect
effect
polysaccharid
sulfat
polymannuroguluron
spmg
note
earlier
current
phase
ii
clinic
trial
china
antiaid
drug
candid
spmg
appear
decreas
tatstimul
calcium
overload
neuron
cell
well
concomit
apoptosissign
cascad
thu
demonstr
potenti
clinic
develop
therapeut
intervent
hivassoci
dementia
tabl
list
marin
compound
miscellan
pharmacolog
mechan
action
respect
structur
present
fig
addit
pharmacolog
data
unavail
possibl
assign
marin
compound
particular
drug
class
possibl
compound
includ
tabl
tabl
show
marin
natur
product
peerreview
literatur
report
pharmacolog
activ
ic
molecular
mechan
action
affect
respect
compound
azumamid
e
fucoxanthin
okada
acid
saproxanthin
myxol
sarcomilasterol
spirastrellolid
c
e
spongia
sesterterpenoid
stylissadin
b
symbiodinolid
contrast
although
pharmacolog
activ
describ
ic
inhibit
enzym
receptor
determin
detail
molecular
mechan
action
studi
unavail
time
public
follow
marin
compound
includ
tabl
asteria
amurensi
saponin
botryti
sp
deriv
sargassum
siliquastrum
meroditerpenoid
symphyocladia
latiuscula
bromophenol
tenacibactin
c
sever
review
cover
gener
specif
subject
area
marin
pharmacolog
publish
gener
marin
pharmacolog
marin
natur
product
emphasi
sourc
organ
relev
biolog
activ
blunt
et
al
blunt
et
al
valu
natur
product
futur
pharmaceut
discoveri
structur
bioactiv
secondari
metabolit
cyanobacteria
gademann
portmann
bioactiv
natur
product
marin
cyanobacteria
drug
discoveri
tan
lt
bioactiv
compound
fungi
south
china
sea
pan
et
al
biochem
pharmacolog
function
alkaloid
cao
et
al
pharmacolog
properti
lamellarin
alkaloid
kluza
et
al
biolog
activ
brown
seawe
fucoidan
kusaykin
et
al
potenti
pharmacolog
use
marin
green
alga
polysaccharid
ulvan
lahay
robic
pharmacolog
properti
marin
bisand
trisindol
alkaloid
gupta
et
al
b
antimicrobi
marin
pharmacolog
renaiss
genom
antibacteri
discoveri
actinomycet
baltz
rh
mine
marin
genom
novel
drug
discoveri
phytosymbiont
marin
invertebr
dunlap
et
al
c
anticoagul
cardiovascular
pharmacolog
structur
biolog
evolut
medic
import
sulfat
fucan
galactan
potenti
antithrombot
compound
pomin
mourao
antituberculosi
antimalari
antifung
marin
pharmacolog
natur
product
growth
inhibitor
mycobacterium
tuberculosi
copp
pearc
new
advanc
novel
marin
fatti
acid
antimalari
antimycobacteri
antifung
agent
carballeira
nm
depsipeptid
microorgan
new
class
antimalari
foti
morgan
manzamin
alkaloid
control
malaria
tuberculosi
hamann
mt
e
immunoand
antiinflammatori
marin
pharmacolog
chemistri
biolog
antiinflammatori
marin
natur
product
abad
et
al
marin
natur
product
target
modul
transcript
factor
folmer
et
al
glycolipid
immunostimul
agent
f
nervou
system
marin
pharmacolog
marinederiv
drug
neurolog
martinez
neuritogen
gangliosid
marin
echinoderm
higuchi
et
al
g
miscellan
molecular
target
enzym
inhibitor
marin
invertebr
nakao
fusetani
natur
product
aromatas
inhibitor
baluna
et
al
biolog
aeruginosin
famili
serin
proteas
inhibitor
ersmark
et
al
marin
natur
product
affect
membran
intracellular
process
ion
channel
folmer
et
al
six
year
approv
marin
compound
ziconotid
us
food
drug
administr
william
et
al
global
marin
preclin
pharmaceut
pipelin
remain
activ
marin
pharmaceut
clinic
pipelin
avail
http
marinepharmacologymidwesterneduclindevhtm
recent
review
mayer
et
al
current
marin
preclin
pipelin
review
contribut
annual
review
seri
initi
mayer
lehmann
mayer
hamann
mayer
et
al
mayer
et
al
reveal
breadth
preclin
pharmacolog
research
result
global
effort
natur
product
chemist
pharmacologist
argentina
australia
brazil
canada
china
egypt
franc
germani
india
israel
itali
japan
netherland
new
zealand
panama
papua
new
guinea
portug
russia
south
korea
spain
switzerland
taiwan
thailand
turkey
unit
kingdom
vietnam
unit
state
thu
appear
marin
preclin
pharmaceut
pipelin
continu
contribut
novel
pharmacolog
lead
compound
probabl
enabl
futur
expans
marin
clinic
pharmaceut
pipelin
current
consist
compound
phase
ii
iii
clinic
develop
mayer
et
al
